Macrophages in the liver prevent metastasis by efficiently eliminating circulating tumor cells after monoclonal antibody immunotherapy

OncoImmunology

Volumn 3, Issue 4, 2014, Pages

  Gül, Nuray ^a   Babes, Liane ^b   Kubes, Paul ^b   Van Egmond, Marjolein ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Antibody dependent cellular phagocytosis; Fc receptors; Kupffer cells; Liver metastasis,mAbs

Indexed keywords

CD20 ANTIBODY; FC RECEPTOR IIA; MONOCLONAL ANTIBODY; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RITUXIMAB;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; B CELL LYMPHOMA; CANCER GROWTH; CANCER SURVIVAL; CELL KILLING; CIRCULATING TUMOR CELL; DRUG MECHANISM; HUMAN; KUPFFER CELL; LIVER METASTASIS; METASTASIS INHIBITION; NATURAL KILLER CELL; NONHUMAN; PHAGOCYTOSIS; PHAGOLYSOSOME; PROGRESSION FREE SURVIVAL; PROTEIN POLYMORPHISM; TUMOR CELL;

EID: 84902593820     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.28441     Document Type: Article

References (10)

1. Scott AM, Wolchok JD, Old LJ. Antibody therapy of cancer. Nat Rev Cancer 2012; 12:278-87; PMID:22437872; http://dx.doi.org/10.1038/ nrc3236
2. Clynes RA, Towers TL, Presta LG, Ravetch JV. Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets. Nat Med 2000; 6:443-6; PMID:10742152; http://dx.doi.org/10.1038/74704
3. Gül N, Babes L, Siegmund K, Korthouwer R, Bögels M, Braster R, Vidarsson G, ten Hagen TL, Kubes P, van Egmond M. Macrophages eliminate circulating tumor cells after monoclonal antibody therapy. J Clin Invest 2014; 124:812-23; PMID:24430180; http:// dx.doi.org/10.1172/JCI66776
4. Otten MA, van der Bij GJ, Verbeek SJ, Nimmerjahn F, Ravetch JV, Beelen RH, van de Winkel JG, van Egmond M. Experimental antibody therapy of liver metastases reveals functional redundancy between Fc gammaRI and Fc gammaRIV. J Immunol 2008; 181:6829-36; PMID:18981101
5. Minard-Colin V, Xiu Y, Poe JC, Horikawa M, Magro CM, Hamaguchi Y, Haas KM, Tedder TF. Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV. Blood 2008; 112:1205-13; PMID:18495955; http://dx.doi. org/10.1182/blood-2008-01-135160
6. Montalvao F, Garcia Z, Celli S, Breart B, Deguine J, Van Rooijen N, Bousso P. The mechanism of anti-CD20-mediated B cell depletion revealed by intravital imaging. J Clin Invest 2013; 123:5098-103; PMID:24177426; http://dx.doi.org/10.1172/ JCI70972
7. Overdijk MB, Verploegen S, Bleeker WK, Parren PW. Role of IgG Fc Receptors in monoclonal antibody therapy of cancer. Chapter 13, Antibody Fc: Linking Adaptive and Innate Immunity. Elsevier. 2014.
8. Grugan KD, McCabe FL, Kinder M, Greenplate AR, Harman BC, Ekert JE, van Rooijen N, Anderson GM, Nemeth JA, Strohl WR, et al. Tumor-associated macrophages promote invasion while retaining Fc-dependent anti-tumor function. J Immunol 2012; 189:5457-66; PMID:23105143; http://dx.doi. org/10.4049/jimmunol.1201889
9. Groot Koerkamp B, Rahbari NN, Büchler MW, Koch M, Weitz J. Circulating tumor cells and prognosis of patients with resectable colorectal liver metastases or widespread metastatic colorectal cancer:a meta-analysis. Ann Surg Oncol 2013; 20:2156-65; PMID:23456317; http://dx.doi.org/10.1245/ s10434-013-2907-8
10. Gül N, Bögels M, Grewal S, van der Meer AJ, Rojas LB, Fluitsma DM, van den Tol MP, Hoeben KA, van Marle J, de Vries HE, et al. Surgery-induced reactive oxygen species enhance colon carcinoma cell binding by disrupting the liver endothelial cell lining. Gut 2011; 60:1076-86; PMID:21278144; http://dx.doi. org/10.1136/gut.2010.224717